Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02263898
Title Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Jonsson Comprehensive Cancer Center



Binimetinib + Encorafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Jonsson Comprehensive Cancer Center Los Angeles California 90095 United States Details
*Shaded cells indicate that there was no data available from for the field